Telomerized human microvasculature is functional in vivo

Previously we showed the superior in vitro survival of human telomerase reverse transcriptase (hTERT)-transduced human endothelial cells (EC). Here we show that retroviral-mediated transduction of hTERT in human dermal microvascular EC (HDMEC) results in cell lines that form microvascular structures when subcutaneously implanted in severe combined immunodeficiency (SCID) mice. Anti-human type IV collagen basement membrane immunoreactivity and visualization of enhanced green fluorescent protein (eGFP)-labeled microvessels confirmed the human origin of these capillaries. No human vasculature was observed after implantation of HT1080 fibrosarcoma cells, 293 human embryonic kidney cells, or human skin fibroblasts. Intravascular red fluorescent microspheres injected into host circulation were found within green “telomerized” microvessels, indicating functional murine–human vessel anastamoses. Whereas primary HDMEC-derived vessel density decreased with time, telomerized HDMEC maintained durable vessels six weeks after xenografting. Modulation of implant vessel density by exposure to different angiogenic and angiostatic factors demonstrated the utility of this system for the study of human microvascular remodeling in vivo.

[1]  J. Lautenberger,et al.  A human vascular endothelial cell model to study angiogenesis and tumorigenesis. , 1998, Carcinogenesis.

[2]  A. Passaniti,et al.  Altered angiogenesis underlying age-dependent changes in tumor growth. , 1994, Journal of the National Cancer Institute.

[3]  D. Whikehart,et al.  Relationship of telomeres and p53 in aging bovine corneal endothelial cell cultures. , 2000, Investigative ophthalmology & visual science.

[4]  A. Passaniti,et al.  An in vivo angiogenesis assay to study positive and negative regulators of neovascularization. , 1999, Methods in molecular medicine.

[5]  D. Shelton,et al.  Microarray analysis of replicative senescence , 1999, Current Biology.

[6]  M. Reed,et al.  A deficit in collagenase activity contributes to impaired migration of aged microvascular endothelial cells , 2000, Journal of cellular biochemistry.

[7]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. White,et al.  Absence of cancer–associated changes in human fibroblasts immortalized with telomerase , 1999, Nature Genetics.

[9]  P. Hornsby,et al.  Formation of functional tissue from transplanted adrenocortical cells expressing telomerase reverse transcriptase , 2000, Nature Biotechnology.

[10]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[11]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[12]  J. Shay,et al.  The use of telomerized cells for tissue engineering , 2000, Nature Biotechnology.

[13]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[14]  T. Scott‐Burden.  Vascular Disease: Molecular Biology and Gene Therapy Protocols , 2000 .

[15]  J. Gamble,et al.  Characterization of a spontaneously transformed human endothelial cell line. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[16]  D. Roeder,et al.  Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. , 1990, Science.

[17]  H. Kleinman,et al.  Impaired wound repair and delayed angiogenesis in aged mice. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[18]  G. S. Herron,et al.  Interleukin‐1 induces major phenotypic changes in human skin microvascular endothelial cells , 1997, Journal of cellular physiology.

[19]  J. Isner,et al.  Age-dependent impairment of angiogenesis. , 1999, Circulation.

[20]  S. Rafii,et al.  BMEC-1: a human bone marrow microvascular endothelial cell line with primary cell characteristics. , 1996, Microvascular Research.

[21]  Caleb S. Stone,et al.  Progress and Problems , 1961 .

[22]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[23]  Andrea Bodnar,et al.  Human Endothelial Cell Life Extension by Telomerase Expression* , 1999, The Journal of Biological Chemistry.

[24]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[25]  R K Jain,et al.  Growth factors: Formation of endothelial cell networks , 2000, Nature.

[26]  G Tellides,et al.  In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. A. Quarles,et al.  Progress and problems , 1953, Electrical Engineering.

[28]  Xu-Rong Jiang,et al.  Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype , 1999, Nature Genetics.

[29]  Sam W. Lee,et al.  Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells , 1997, Oncogene.

[30]  Rakesh K. Jain,et al.  Quantitative angiogenesis assays: Progress and problems , 1997, Nature Medicine.

[31]  C. Harley,et al.  Telomere length and replicative aging in human vascular tissues. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Nolan,et al.  Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. , 1996, Human gene therapy.

[33]  R. Azizkhan,et al.  Isolation and characterization of an established endothelial cell line from transgenic mouse hemangiomas. , 1991, Experimental cell research.

[34]  A. Passaniti,et al.  A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[35]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[36]  J. V. van Mourik,et al.  Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA. , 1995, Experimental cell research.

[37]  R Folberg,et al.  Vasculogenic mimicry and tumor angiogenesis. , 2000, The American journal of pathology.

[38]  H. DeLisser,et al.  Expression and function of endothelial cell alpha v integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras. , 1997, The American journal of pathology.

[39]  D. Mooney,et al.  Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. , 1999, The American journal of pathology.

[40]  R. Swerlick,et al.  HMEC-1: establishment of an immortalized human microvascular endothelial cell line. , 1992, The Journal of investigative dermatology.

[41]  R K Jain,et al.  Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Meltzer,et al.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.

[43]  F A Auger,et al.  A completely biological tissue‐engineered human blood vessel , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.